5-phenylbicyclo[2.2.1]heptane-2,3-dicarboxylic acid, 1g

2-Amino-5-(ethylthio)-1,3,4-thiadiazole, 25g

2,3,4-Trifluorotoluene>97.0%(GC)1g

2-(2,4-Dimethoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 25g

3-(5-NITRO-1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE, 95%, 5g

3-Bromo-2-fluorobenzenesulfonyl chloride, 95.0%, 25g

2-Amino-6-phenyl-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carboxylic acid methyl ester, 95.0%, 5g

1-Cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

valerenic acid, with analyt. Documents, 50 mg, glass packaging

3-Bromo-1,4-dimethyl-1H-pyrazole, 97%, 100mg

(R)-2,2'-Bis(methoxymethoxy)-1,1'-binaphthyl>98.0%(GC)1g

N-Methyl-1H-pyrrolo[2,3-b]pyridin-6-amine, 95.0%, 100mg

2,4,7-Trichloropyrido[2,3-d]pyrimidine, 95.0%, 100mg